Search research articles
Contact Us
Filters
Showing results (61-70 of 150) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2000
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer
M Terzolo, A Pia, A Berruti, et al.
The Prostate
|
May 15, 2001
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients
A Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology
|
February 26, 1999
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer
A Berruti, L Dogliotti, G Fasolis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Melatonin and human cancer
L Dogliotti, A Berruti, T Buniva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
S Filetti, C Durante, D M Hartl, et al.
Critical Reviews in Oncology/Hematology
|
August 30, 2008
Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service
D Marenco, R Marinello, A Berruti, et al.
Calcified Tissue International
|
November 14, 1997
Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease
A Piovesan, A Berruti, M Torta, et al.
Sexually Transmitted Diseases
|
August 10, 2022
The Cost of Operating Sexual Health Clinics During the Ending the (HIV) Epidemic Initiative in New York City
Austin M Williams, Kelly Jamison, Samuel T Eppink, et al.
Cancer
|
June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinoma
A Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology
|
September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline
A Berruti, L Dogliotti, R Bitossi, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 150) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2000
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer
M Terzolo, A Pia, A Berruti, et al.
The Prostate
|
May 15, 2001
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients
A Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology
|
February 26, 1999
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancer
A Berruti, L Dogliotti, G Fasolis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Melatonin and human cancer
L Dogliotti, A Berruti, T Buniva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2022
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer
S Filetti, C Durante, D M Hartl, et al.
Critical Reviews in Oncology/Hematology
|
August 30, 2008
Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service
D Marenco, R Marinello, A Berruti, et al.
Calcified Tissue International
|
November 14, 1997
Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease
A Piovesan, A Berruti, M Torta, et al.
Sexually Transmitted Diseases
|
August 10, 2022
The Cost of Operating Sexual Health Clinics During the Ending the (HIV) Epidemic Initiative in New York City
Austin M Williams, Kelly Jamison, Samuel T Eppink, et al.
Cancer
|
June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinoma
A Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology
|
September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline
A Berruti, L Dogliotti, R Bitossi, et al.
Page
of 15